spacer
The Healthcare Sales & Marketing Network celebrates 21 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Sciele Pharma 

 HSMN NewsFeed - 10 Apr 2017
Repros Names Larry Dillaha, M.D., its Permanent President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jan 2010
Shionogi Pharma Appoints Ray Russo as Vice President, Primary Care Business Unit
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jul 2009
Sciele Pharma and Plethora Solutions Announce Positive Results of Final Phase III Pivotal Trial for PSD502 for Premature Ejaculation
Biopharmaceuticals
 HSMN NewsFeed - 10 Jul 2009
Sciele Pharma, a Shionogi Company, Terminates Agreement to Acquire Victory Pharma, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 May 2009
InVasc Therapeutics Announces Executive and Board Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Apr 2009
Sciele Pharma and Addrenex Pharmaceuticals Announce Positive Phase III Clinical Results of Clonicel Used in Combination with Stimulants to Treat ADHD
Biopharmaceuticals
 HSMN NewsFeed - 19 Sep 2008
Shionogi and Sciele Announce Receipt of United States Antitrust Clearance
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Sep 2008
Dr. Michael Beckert Steps Down as EVP and CMO of LifeCycle Pharma Effective December 31, 2008
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Aug 2008
LifeCycle Pharma Sells Fenoglide(TM) Royalty Stream to Cowen Healthcare Royalty Partners for up to USD 105 Million Including an Upfront Payment of USD 29 Million
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 28 Jul 2008
Mylan Launches First Generic Version of Antihypertensive Sular(R) ER in the United States
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 1 Jul 2008
Sciele Pharma Signs Agreement with Addrenex Pharmaceuticals To Develop and Market ADX415 for the Treatment of Hypertension
Biopharmaceuticals
 HSMN NewsFeed - 24 Jun 2008
FDA Approves PrandiMet(TM), a Replaglinide and Metformin Fixed-Dose Combination Tablet for Treatment of Type 2 Diabetes
Biopharmaceuticals FDA Endocrinology
 HSMN NewsFeed - 13 Mar 2008
Sciele Pharma Acquires Twinject(R) Epinephrine Auto-Injector from Verus Pharmaceuticals
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 25 Feb 2008
Sciele Expands Alliance with Sanofi-Aventis to Market Allegra(R) (Fexofenadine HCL) Orally Disintegrating Tablets (ODT) and Allegra(R) Oral Suspension (OS) in the U.S.
Biopharmaceuticals
 HSMN NewsFeed - 21 Feb 2008
Sciele Pharma and LifeCycle Pharma Announce U.S. Market Launch of Fenoglide(TM)
Biopharmaceuticals
 HSMN NewsFeed - 21 Feb 2008
LifeCycle Pharma Launches Its First Product in the U.S.
Biopharmaceuticals
 HSMN NewsFeed - 2 Jan 2008
Sciele Pharma Announces FDA Approval of New Sular(R) Formulation
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 5 Dec 2007
Edward J. Schutter Appointed to President and Chief Operating Officer of Sciele Pharma, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Nov 2007
Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R)
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 19 Nov 2007
Sciele Signs Exclusive Agreement with Novo Nordisk to Market Prandin(R) and PrandiMet(R)
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 30 Oct 2007
Sciele Pharma and Addrenex Announce Initiation of Pivotal Phase III Trials for Clonicel for ADHD
Biopharmaceuticals
 HSMN NewsFeed - 13 Aug 2007
Sciele Pharma and Lifecycle Pharma Announce FDA Approval of New Formulation of Fenofibrate in 120 Mg. and 40 Mg. Dosage Strengths
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 16 Jul 2007
Sciele Pharma Acquires a Novel, Patented Treatment for Head Lice from Summers Laboratories, Inc.
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 12 Jul 2007
Sciele Pharma Signs Agreement with Addrenex Pharmaceuticals to Market CLONICEL(R)
Biopharmaceuticals
 HSMN NewsFeed - 12 Jun 2007
Sciele Pharma Completes Acquisition of Alliant Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 May 2007
Sciele Enters Into Exclusive License Agreement with Plethora Solutions Limited to Market PSD502 for the Treatment of Premature Ejaculation
Biopharmaceuticals Licensing
 HSMN NewsFeed - 24 Apr 2007
Sciele Pharma to Acquire Alliant Pharmaceuticals, a Pediatric Specialty Pharmaceutical Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Apr 2007
Sciele Begins to Enroll Patients in a Pivotal Phase III Clinical Trial for the Combination of Pravastatin and Fenofibrate
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 20 Dec 2006
Sciele Pharma Signs Exclusive Zovirax(R) Promotional Agreement with Biovail
Biopharmaceuticals
 HSMN NewsFeed - 20 Dec 2006
Biovail Enters into Exclusive Promotional Agreement for Zovirax(R)
Biopharmaceuticals
 HSMN NewsFeed - 28 Sep 2006
Sciele Pharma Introduces OSTIVA(TM), a New Women's Health Product
Biopharmaceuticals
 HSMN NewsFeed - 15 Jun 2006
First Horizon Pharmaceutical Corporation Stockholders Approve Name Change to Sciele Pharma, Inc.
Biopharmaceuticals
Return to NewsFeed  
FindReps 2 - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps 2 - available on the Apple App Store for iPhone and iPad.